Bone Grafts and Substitutes Market to Amass a Revenue of US$ 4.44 Billion by the end of 2028

The global bone grafts and substitutes market was estimated to be worth US$ 3.06 billion in 2020 by Fact.MR, a supplier of market research and competitive information. In 2020, the bone transplants and alternatives was valued at US$ 3.06 billion. By the end of 2028, sales of bone grafts and substitutes are expected to increase at a CAGR of 4.9% and reach US$ 4.44 billion.

Materials known as "bone grafts and substitutes" (BGS) are utilised to reconstruct broken or missing bones. BGS is frequently utilised in musculoskeletal injuries, fractures, and surgeries involving the hip, foot, and ankle.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7229?AS

Key Statistics Supporting the Surge

• AlloSource
• Integra LifeSciences
• NuVasive, Inc.
• Stryker
• Wright Medical Group N.V.
• Xtant Medical
• Zimmer Biomet
• Baxter Healthcare Corporation
• Medtronic plc

Key Takeaways:

• North America is projected to witness 53.1% share of the bone grafts and substitutes market over the forecast period attributed to the surge in prevalence of spine-related diseases, as well as the growing geriatric population.
• The bone grafts and substitutes market in China is growing due to an increase in the usage of allografts and other alternative products, a steady supply of orthopedic equipment, and a growing acceptance of autograft bone.
• Hospitals are expected to dominate the global market during the forecast period owing to rising prevalence of various chronic bone disorders across the globe.
• Factors such as rise in orthopedic surgical operations, a transition from non-biodegradable bone graft substitutes to biodegradable bone graft substitutes, and new product releases are expected to be the primary influencing factors in driving the bone grafts and substitutes market growth.
• Rise in public knowledge of commercially available new products, a strong presence of bone graft and substitute producers, and increased healthcare expenditure are all factors contributing to growth of the market.

Competitive Dashboard

Bone grafts manufacturers are constantly investing in the development of new products with improved bioactivity, biocompatibility, and mechanical qualities. Companies have a varied product portfolio that is technologically advanced, as well as a larger global presence. Key players in the market are putting emphasis on innovative products in various orthopedic application areas.

For instance,

• Synthes, Inc, a Johnson & Johnson Company is a manufacturer of chronOS Strip bone graft substitute. The chronOS-tricalcium phosphate granules in this synthetic bone transplant can be perfused with the patient's bone marrow and blood.

More Valuable Insights on Bone Grafts and Substitutes Market

• By Product:

o Allografts
 Demineralized Bone Matrix (DBM)
 Others
o Synthetic Bone Grafts
o Others

• By Material:

o Ceramic-based Bone Grafts and Substitutes
 Calcium Phosphate
 Calcium Sulfate
 Others

o Polymer-based Bone Grafts and Substitutes
 Polylactides
 Polyglycolides
 Polyurethanes
 Others

o Growth Factor-based Bone Grafts and Substitutes
o Cell-based Bone Grafts and Substitutes
o Others

• By End User:

o Hospitals
o Orthopedic Clinics
o Others

• By Region:

o North America
o Europe
o Asia Pacific
o Latin America
o Middle East & Africa

The report will improve the revenue impact of businesses in various industries by:

• Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global market and offers solutions
• Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
• Helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising synergies for top players aiming to retain their leadership position in the market.

How can Fact.MR Make Difference?

• In-depth understanding of key industry trends shaping the present growth dynamics
• Offers value chain analysis and price trend analysis of various offering of competitors
• Offers data-drive decision to help companies decide strategies that need recalibration
• Offers insights into areas in research and development that should attract
• Identifies data outliers before your competitors

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7229?AS

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.

This release was published on openPR.